Cargando…
HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells
Drug resistance is the leading cause of chemotherapy failure in the treatment of ovarian cancer. So far, little is known about the mechanism of chemoresistance in ovarian cancer. In this study, we explored the mechanism that HSP27 was involved in cisplatin resistance of ovarian cancer both in vitro...
Autores principales: | Lu, Hao, Sun, Chaoyang, Zhou, Ting, Zhou, Bo, Guo, Ensong, Shan, Wanying, Xia, Meng, Li, Kezhen, Weng, Danhui, Meng, Li, Xu, Xiaoyan, Hu, Junbo, Ma, Ding, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838724/ https://www.ncbi.nlm.nih.gov/pubmed/26931434 http://dx.doi.org/10.3727/096504015X14496932933656 |
Ejemplares similares
-
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
por: Xia, Xi, et al.
Publicado: (2011) -
A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
por: Sun, Chaoyang, et al.
Publicado: (2019) -
Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
por: Sun, Chaoyang, et al.
Publicado: (2020) -
The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients
por: Zhou, Bo, et al.
Publicado: (2019) -
Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis
por: Shan, Wanying, et al.
Publicado: (2016)